TY - JOUR
T1 - RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity
AU - Chin, D. W.L.
AU - Sakurai, M.
AU - Nah, G. S.S.
AU - Du, L.
AU - Jacob, B.
AU - Yokomizo, T.
AU - Matsumura, T.
AU - Suda, T.
AU - Huang, G.
AU - Fu, X. Y.
AU - Ito, Y.
AU - Nakajima, H.
AU - Osato, M.
N1 - Publisher Copyright:
© 2016, Nature Publishing Group. All rights reserved.
PY - 2016/1/8
Y1 - 2016/1/8
N2 - RUNX1/AML1 is among the most commonly mutated genes in human leukemia. Haploinsufficiency of RUNX1 causes familial platelet disorder with predisposition to myeloid malignancies (FPD/MM). However, the molecular mechanism of FPD/MM remains unknown. Here we show that murine Runx1+/- hematopoietic cells are hypersensitive to granulocyte colony-stimulating factor (G-CSF), leading to enhanced expansion and mobilization of stem/progenitor cells and myeloid differentiation block. Upon G-CSF stimulation, Runx1+/- cells exhibited a more pronounced phosphorylation of STAT3 as compared with Runx1+/+ cells, which may be due to reduced expression of Pias3, a key negative regulator of STAT3 signaling, and reduced physical sequestration of STAT3 by RUNX1. Most importantly, blood cells from a FPD patient with RUNX1 mutation exhibited similar G-CSF hypersensitivity. Taken together, Runx1 haploinsufficiency appears to predispose FPD patients to MM by expanding the pool of stem/progenitor cells and blocking myeloid differentiation in response to G-CSF.
AB - RUNX1/AML1 is among the most commonly mutated genes in human leukemia. Haploinsufficiency of RUNX1 causes familial platelet disorder with predisposition to myeloid malignancies (FPD/MM). However, the molecular mechanism of FPD/MM remains unknown. Here we show that murine Runx1+/- hematopoietic cells are hypersensitive to granulocyte colony-stimulating factor (G-CSF), leading to enhanced expansion and mobilization of stem/progenitor cells and myeloid differentiation block. Upon G-CSF stimulation, Runx1+/- cells exhibited a more pronounced phosphorylation of STAT3 as compared with Runx1+/+ cells, which may be due to reduced expression of Pias3, a key negative regulator of STAT3 signaling, and reduced physical sequestration of STAT3 by RUNX1. Most importantly, blood cells from a FPD patient with RUNX1 mutation exhibited similar G-CSF hypersensitivity. Taken together, Runx1 haploinsufficiency appears to predispose FPD patients to MM by expanding the pool of stem/progenitor cells and blocking myeloid differentiation in response to G-CSF.
UR - https://www.scopus.com/pages/publications/84953775209
UR - https://www.scopus.com/pages/publications/84953775209#tab=citedBy
U2 - 10.1038/bcj.2015.105
DO - 10.1038/bcj.2015.105
M3 - Article
C2 - 26745853
AN - SCOPUS:84953775209
SN - 2044-5385
VL - 6
JO - Blood cancer journal
JF - Blood cancer journal
M1 - e379
ER -